Delivery Order SPE2DB22D3401-SPE2DB24FT4AY

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,668.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of 4566054521 ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of October 9, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen has been awarded...
This federal contract award, valued at $5,980.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, worth up to $2,175.16, is a Delivery Order for the supply of a specific pharmaceutical product, ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of August 21, 2024, and is a Firm Fixed Price arrangement. Amerisourcebergen, through its Corporate Office...
This federal contract award, valued at $9,108.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corporation holds a...
This federal contract award, valued at $16,398.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of September 12, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been...
This federal contract award, valued at $4,559.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of May 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $26,371.33 firm-fixed-price delivery order is for the supply of the medication ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. This award is not associated with a set-aside program. Amerisourcebergen's Corporate Office Division will provide the requested pharmaceutical product to support military treatment facilities and other federal...
This federal contract award, valued at $1,153.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of 4565504802 ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a type of medication. There is no set-aside designation for this award. The contract has an ultimate completion date of August 20, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen has been awarded numerous...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.30 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office division. The $2,272.83 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4AY
    Delivery Order

This federal contract award, valued at $2,342.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,321,148 units of the pharmaceutical product ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies, including the DLA Troop Support Medical program and the Department of Justice Federal Bureau of Investigation. These contracts enable the government to efficiently procure essential medical commodities, such as specialty medications, generic drugs, and medical supplies, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 10/31/24, 9:30 AM